Cell cycle deregulation in B-cell lymphomas

M Sánchez-Beato… - Blood, The Journal of …, 2003 - ashpublications.org
Disruption of the physiologic balance between cell proliferation and death is a universal
feature of all cancers. In general terms, human B-cell lymphomas can be subdivided into 2 …

[HTML][HTML] B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

JP Vaqué, N Martínez, A Batlle-López, C Pérez… - …, 2014 - ncbi.nlm.nih.gov
B-cell lymphomas comprise an increasing number of clinicopathological entities whose
characterization has historically been based mainly on histopathological features. In recent …

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study

KH Young, K Leroy, MB Møller… - Blood, The Journal …, 2008 - ashpublications.org
The purpose of this study is to correlate the presence of TP53 gene mutations with the
clinical outcome of a cohort of patients with diffuse large B-cell lymphoma (DLBCL) …

PLCG1 mutations in cutaneous T-cell lymphomas

JP Vaqué, G Gómez-López… - Blood, The Journal …, 2014 - ashpublications.org
Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of primary cutaneous T-cell
lymphoproliferative processes, mainly composed of mycosis fungoides and Sézary …

Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases

FI Camacho, M Mollejo, MS Mateo… - The American journal …, 2001 - journals.lww.com
Splenic marginal zone lymphoma (SMZL) is considered to be an indolent extranodal B-cell
lymphoma. Despite its low aggressivity, histologic progression has been described in …

Cancer induction by restriction of oncogene expression to the stem cell compartment

M Pérez‐Caro, C Cobaleda, I González‐Herrero… - The EMBO …, 2009 - embopress.org
In human cancers, all cancerous cells carry the oncogenic genetic lesions. However, to
elucidate whether cancer is a stem cell‐driven tissue, we have developed a strategy to limit …

Molecular heterogeneity in MCL defined by the use of specificVH genes and the frequency of somatic mutations

FI Camacho, P Algara, A Rodrıguez… - Blood, The Journal …, 2003 - ashpublications.org
This study explores whether the presence of somatic mutations or a biased use of IgV H
genes were associated with the clinical features in a series of 96 patients with mantle cell …

[HTML][HTML] MicroRNA signatures in B-cell lymphomas

L Di Lisio, M Sánchez-Beato, G Gómez-López… - Blood cancer …, 2012 - nature.com
Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We
explore the potential relevance of microRNA (miRNA) expression in a large series that …

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets

AJ Arribas, Y Campos-Martín… - Blood, The Journal …, 2012 - ashpublications.org
Nodal marginal zone lymphoma (NMZL) is a small B-cell neoplasm whose molecular
pathogenesis is still essentially unknown and whose differentiation from other small B-cell …

Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases

FI Camacho, P Algara, M Mollejo… - The American journal …, 2003 - journals.lww.com
We have reviewed the clinical, morphologic, immunophenotypical, and molecular features of
a series of 27 cases of nodal marginal zone lymphoma with the aim of defining this entity …